Mitochondrial dysfunction has been suggested to be a risk factor for sensorineural hearing loss (SNHL) induced by aging, noise, ototoxic drugs, and gene. Reactive oxygen species (ROS) are mainly derived from mitochondria, and oxidative stress induced by ROS contributes to cochlear damage as well as mitochondrial DNA mutations, which may enhance the sensitivity and severity of hearing loss and disrupt ion homeostasis (e.g., Ca2+ homeostasis). The formation and accumulation of ROS further undermine mitochondrial components and ultimately lead to apoptosis and necrosis. SIRT3–5, located in mitochondria, belong to the family of sirtuins, which are highly conserved deacetylases dependent on nicotinamide adenine dinucleotide (NAD+). These deacetylases regulate diverse cellular biochemical activities. Recent studies have revealed that mitochondrial sirtuins, especially SIRT3, modulate ROS levels in hearing loss pathologies. Although the precise functions of SIRT4 and SIRT5 in the cochlea remain unclear, the molecular mechanisms in other tissues indicate a potential protective effect against hearing loss. In this review, we summarize the current knowledge regarding the role of mitochondrial dysfunction in hearing loss, discuss possible functional links between mitochondrial sirtuins and SNHL, and propose a perspective that SIRT3–5 have a positive effect on SNHL.
National Natural Science Foundation of China8170091781771016818300301. Introduction
Hearing loss is a common sensory disorder with high prevalence. About 500 million people in the world suffer from hearing loss [1]. It can not only cause impaired communication, but also affect the physical and mental health of individuals and social and economic development. It has been proposed that the elderly with hearing loss have higher rates of dementia, depression, and death [2]. Hearing loss is often classified as conductive, sensorineural, or mixed according to anatomical deficit [2, 3]. Sensorineural hearing loss is caused by dysfunction of cochlea or auditory nerve, which is the commonest in adult primary care [2, 3].
Many previous studies have suggested that mitochondrial dysfunction is involved in the etiology of several types of sensorineural hearing loss (SNHL), such as noised-induced hearing loss (NIHL), age-related hearing loss (ARHL), ototoxic drug-induced hearing loss (ODIHL), and inherited hearing loss. In most mammalian cells, mitochondria are the main source of reactive oxygen species (ROS) [4, 5, 6]. Increased ROS formation results in further damage to the mitochondrial structure, including mitochondrial membranes, mitochondrial DNA (mtDNA), respiratory chain proteins, and nuclear DNA related to mitochondrial functions [7]. SNHL occurs because of the irreversible damage to hair cells (HCs) and spiral ganglion neurons (SGNs), both of which have very limited regeneration ability in adult mice cochlea [8, 9, 10, 11, 12, 13].
Sirtuins are histone deacetylases dependent on NAD+ that remove various cellular proteins’ acyl modifications [14]. They regulate metabolism, differentiation, stress responses, apoptosis, and the cell cycle [15, 16]. Seven members of the sirtuin family (named SIRT1–7) have been identified with different locations in the cell. Recent studies have revealed that mitochondrial sirtuins, especially SIRT3, modulate ROS levels in hearing loss pathologies and indicated that SIRT4 and SIRT5 may have a potential protective effect against hearing loss. In this review, we focus on mitochondrial dysfunction and the role of mitochondrial sirtuins in SNHL, as shown in Figures 1 and 2.
Stimulations induce ROS and mitochondrial dysfunction and finally cells’ apoptosis. Diagram showing aging, noise, and drugs could induce ROS and the probable mechanism to lead to mitochondrial dysfunction, moreover, the interaction between ROS and mitochondrial dysfunction.
Regulation of ROS and protection of mitochondria by sirtuins. The diagram showing possible signaling ways of mitochondrial sirtuins (SIRT3~5) to reduce level of ROS and resist oxidative reaction. Solid lines represent considerable evidence for an interaction while dashed lines suggest putative interactions.
2. Hearing Loss and Mitochondrial Dysfunction2.1. Age-Related Hearing Loss (ARHL)
ARHL, or presbycusis, is a progressive decline in hearing function that is the most prevalent type of SNHL in the elderly [17, 18, 19, 20]. It is characterized by higher hearing thresholds, beginning at high frequencies and spreading toward low frequencies, accompanied by the loss of HCs and SGNs from the basal to apical turn [21, 22, 23, 24, 25, 26]. The mechanism underlying ARHL is considered to be multifactorial, involving environmental and hereditary factors, but remains unclear. Extensive evidence suggests that mitochondria make a large contribution to the pathology of ARHL.
A previous study proposed that the accumulation of mtDNA mutations could result in age-related degenerative diseases like ARHL [27]. Major mtDNA mutations arise in the genes encoding mitochondrial oxidative phosphorylation complexes, resulting in an impairment of its activity [28]. Transgenic PolgA mice with knockout of the functional nuclear gene that encodes the polymerase helping repair damaged mtDNA, POLG D257A, developed hearing loss more rapidly and earlier than their wild-type counterparts. Furthermore, 10-month old PolgA mice showed severe sensorineural degeneration in the basal turn and neural degeneration in the apical turn, including clumping of surviving neurons in the cochlea [29]. On the other hand, mtDNA mutations affect cochlear function by leading to not only mitochondrial dysfunction but also energy metabolic disturbances and induction of apoptosis [30].
Extensive experimental evidence indicates that oxidative stress and ROS are closely associated with the development of ARHL. A suitable model of the senescence-accelerated mouse prone 8 (SAMP8) has been established to study the impact of the aging process on various parameters. In SAMP8 mice, oxidative stress, changes in antioxidant enzyme levels, and impairment in activities of complexes I, II, and IV were shown to be involved in premature ARHL [31]. Moreover, the level of 7,8-dihydro-8-oxoguanine, a crucial biomarker of mitochondrial and nuclear DNA damage in HCs and SGNs [32], increased with aging and mitochondriogenesis decreased, as assessed by the activity of citrate synthase and the ratio of mtDNA to nuclear DNA [31]. After exposure to H2O2 (0.1 mM) for only 1 h in vitro, House Ear Institute-Organ of Corti 1 auditory cells presented with premature senescence, leading to a lower mitochondrial membrane potential (MMP), breakdown of the mitochondrial fusion/fission balance, destruction of mitochondrial morphology, and collapse of the mitochondrial network [33]. Furthermore, oxidative stress and an accumulation of ROS increased expression of the mitochondrial proapoptotic gene Bcl-2-antagonist/killer 1 (Bak) to induce apoptosis. Suppression or deletion of Bak reduced apoptotic cell death of SGNs and HCs and prevented ARHL [34, 35].
As the major source of ROS, mitochondria contain a complex antioxidant system to resist the destructive effects of these species. Isocitrate dehydrogenase 2 (IDH2), which can convert NADP+ to NADPH, is crucial in the mitochondrial response to oxidative stress. In male mice, IDH2 deficiency accelerated the ARHL process, along with increased oxidative DNA damage and apoptosis and a loss of SGNs and HCs [36]. Superoxide dismutase 1 (SOD1-) knockout mice also exhibited premature ARHL, characterized by an early loss of HCs, severe degeneration of SGNs, and leanness of the stria vascularis [37].
Glutathione peroxidase 1 (Gpx1) also has important antioxidant properties. Mice with deletion of Gpx1 showed higher hearing thresholds at high frequencies and extensive damage of HCs [34]. Ggt1dwg/dwg mice, with deletion of the γ-glutamyl transferase 1 gene that encodes an antioxidant enzyme crucial for resynthesizing reduced glutathione (GSH), exhibited an extremely rare type of cochlear pathology in which the function of outer hair cells (OHCs) was unaffected while inner hair cells (IHCs) were unusually and selectively lost. Furthermore, treatment with N-acetyl-L-cysteine could completely prevent the hearing deficit and IHC loss in these mice [38]. In addition, administration of EUK-207, a synthetic SOD/catalase drug, attenuated the senescence phenotype in vitro and mitigated ARHL in SAMP8 mice by increasing the expression of FOXO3A and the mRNA and protein levels of manganese SOD (Mn-SOD) and catalase [39].
Peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) could regulate mitochondrial biogenesis and upregulate the expression of oxidative stress-related genes, including Gpx1, catalase, and Mn-SOD genes [40, 41]. Overexpression of PGC-1α, with a consequent rise in nuclear respiratory factor 1 and mitochondrial transcription factor A, resulted in reduced damage to mtDNA and decreased apoptosis in the strial marginal cell aging model harboring mtDNA4834 deletion [34, 42, 43].
2.2. Noise-Induced Hearing Loss (NIHL)
Excessive exposure to noise from recreation, the environment, and various occupations can lead to hearing loss, known as NIHL, which is one of the most prevalent types of SNHL. Its typical characteristics are an increased hearing threshold, tinnitus, decreased speech discrimination score, and auditory processing disorders [44]. Higher frequencies are preferentially affected, creating a V-shaped dip or notch, around 4 or 6 kHz [45]. The cochlear injury following noise exposure is mainly caused by mechanical damage and biochemical pathways. Generally, OHCs are more sensitive to noise exposure than IHCs [28].
ROS production was observed as an early event in cochlear damage after noise exposure [46]. As the major source of ROS, mitochondria are assumed to be damaged and, in turn, increase the accumulation of ROS. It has also been reported that mitochondrial ROS provide feedback regulation after metabolic excess, autophagy, and the inflammatory response [44]. ROS generate lipid peroxidation products, such as 8-iso-prostaglandin F2α, that reduce blood flow in the cochlea [47], finally resulting in apoptosis [44]. Ischemia may lead to cochlear hypoxia and lower adenosine triphosphate (ATP) levels and further increase the generation of ROS. On the other hand, mitochondria possess a potent antioxidant enzyme system to scavenge ROS, relying on the NADPH pool. Mn-SOD heterozygous knockout mice had worse hearing thresholds, particularly at 4 kHz, and greater damage of OHCs in all cochlear turns after noise exposure and exacerbation of NIHL [14]. In another study, Gpx1-knockout mice exhibited greater HC and nerve fiber loss with higher auditory brainstem response thresholds [48].
Calcium homeostasis is also a significant factor in the occurrence and development of NIHL. After noise exposure, the level of free Ca2+increased immediately in HCs [43, 49]; the probable ion channels allowing entry are L-type Ca2+ and P2X2 ATP-gated channels [50]. Mitochondria modulate cellular calcium homeostasis through selective calcium entry channels, the mitochondrial calcium uniporter (MCU), and the sodium-calcium exchanger with the function of extruding calcium from mitochondria [51]. Inhibiting the MCU in CBA/J mice attenuated the loss of sensory HCs, synaptic ribbons, and the NIHL process. Furthermore, MCU-knockout mice showed resistance to noise-induced seizures and recovery of IHC synaptic connections, the auditory brainstem response, and wave I amplitude after noise exposure [51]. Mitochondrial Ca2+ overload not only results in a decline in the MMP and overproduction of ROS but also triggers ROS-independent apoptotic and necrotic cell death pathways [50, 52, 53].
Before there is a permanent threshold shift caused by noise exposure, the level of 5′-AMP-activated protein kinase (AMPK) is elevated in the spiral ligament of cochlea, in addition to an increased level of phospho-c-Jun N-terminal kinase, and this mediates the activation of apoptosis [54, 28]. Apoptosis occurs through both extrinsic and intrinsic pathways; the latter is activated by the change of mitochondrial membrane permeability. In addition to ROS, cytochrome C and caspase-independent apoptosis-inducing factor increase membrane permeability [28, 50, 55].
2.3. Ototoxic Drug-Induced Hearing Loss (ODIHL)
Platinum-based anticancer drugs, such as cisplatin, and aminoglycoside antibiotics are clinically common ototoxic drugs [56, 57, 58]. Platinum-based anticancer drugs are widely adopted to treat different kinds of cancer, and aminoglycosides are broad-spectrum antibiotics used to treat many life-threatening bacterial infections. Both can lead to hearing loss at high frequencies and preferential damage to OHCs at the cochlea basal turn [43, 59, 60–62, 63, 64].
The ototoxicity of both cisplatin and aminoglycoside antibiotics is modulated by genetic factors, and mitochondrial mutations are well-defined risk factors. Individuals bearing the mtDNA mutation A1555G in the 12S ribosomal RNA gene suffer more profound hearing loss [56, 65, 66]. C1494T is the second most common mutation identified, especially in Chinese populations [67, 68, 69]. Mutations in thiopurine S-methyltransferase (TMPT) and catechol O-methyltransferase (COMT) are related to earlier onset and greater severity of hearing loss induced by cisplatin in children [70]. However, a more recent study revealed that variations in the TMPT or COMT genes may not correspond to cisplatin ototoxicity and did not affect hearing damage induced by cisplatin in mice. Thus, the precise role of these genes in cisplatin ototoxicity remains unclear [71].
Mitochondrial dysfunction and ROS are the main initiators of ODIHL. Aminoglycoside antibiotics, such as gentamicin, tend to accumulate in the mitochondria of HCs through nonselective mechanoelectrical transducer cation channels expressed on the stereociliary membranes of HCs [72–74, 75, 76]. Administration of gentamicin can directly inhibit mitochondrial protein synthesis [28], trigger opening of the mitochondrial permeability transition pore, and lower the MMP [77]. Aminoglycosides can induce the release of arachidonic acid, leading to lipid peroxidation and generation of ROS [78, 79, 80, 81]. The ototoxic effect of aminoglycosides has been proposed to be linked to the formation of iron-aminoglycoside complexes that promote the formation of ROS [82]. Downregulation of tRNA5-methylaminomethyl-2-thiouridylate methyltransferase, a mitochondrial protein, significantly made HEI-OC1 auditory cells more sensitive to damage induced by neomycin [80]. Aminoglycosides also dysregulate calcium homeostasis, facilitating the transfer of Ca2+ into mitochondria [83]. Elevation of mitochondrial Ca2+ levels promotes both mitochondrial oxidation and cytoplasmic ROS prior to cell death [84]. In an in vitro study, mitochondria-specific ROS formation was evaluated in cochlear explants after exposure to gentamicin, which was accompanied by a reduction of NAD(P)H and the MMP [85]. ROS formation in HCs in response to cisplatin leads to depletion of NADPH and binding to the sulfhydryl groups of enzymes [28, 86]. Cisplatin could stimulate the activity of NADPH oxidase 3, a relevant source of ROS, to elevate ROS levels [87]. Oxidative stress induced by cisplatin could lead to GSH depletion, increased lipid peroxidation, and an imbalance of the oxidant/antioxidant systems [43].
Mitochondrial apoptotic pathways are activated following both cisplatin and aminoglycoside cochlear injury through the Bcl-2 family of proteins. After cisplatin treatment, the level of Bax was increased and the level of Bcl-2 was decreased in HCs, spiral ganglia, and the lateral wall [88]. Pretreatment with an adenovector expressing human Bcl-2 (Ad.11D.Bcl-2) could protect HCs and preserve hearing in mice treated with gentamicin [89].
2.4. Inherited Hearing Loss
Sensorineural hearing loss which mainly causes by mutation of genes, known as inherited hearing loss, has been identified more common due to the development of science and technology [90, 91, 92]. Its clinical and genetical characteristics are very heterogeneous [93]. Though the mechanism of many cases remains unclear, large evidence has proved that it has much to do with the mitochondrial function.
13 crucial polypeptides of oxidative phosphorylation were encoded by mitochondrial genome [94]. Mutation in the mitochondria DNA has been proved to be related to the maternally inherited susceptibility in both syndromic and nonsyndromic hearing loss [93]. Mitochondrial disorders including Kearns-Sayre syndrome, MELAS syndrome, and MERRF syndrome are always accompanied by syndromic hearing loss [94]. In view of nonsyndromic hearing loss, extensive research has been carried out to identify the role of A1555G and C1494T mutations in 12S rRNA and emphasize the high susceptibility to hearing loss induced by drugs such as cisplatin and aminoglycoside [95, 65, 66, 96]. Mutation of 7505A>G in the tRNASer(UCN) would lead to mitochondrial dysfunction by lowering the activity of cellular respiratory chain and the level of ATP, MMP, and over produce ROS [97], finally induce cell apoptosis [98]. Other variants in the tRNASer(UCN) including A7445G, T7505C, T7510C, and T7511C alter mitochondrial translation and function, involving in SNHL [95, 99, 100, 101].
The phenotypic expression of variants in mitochondrial DNA could be modulated by nuclear modifier genes, which may also play an important role in inherited hearing loss. Fan et al. had found that the interaction between p.191Gly>Val mutation in mitochondrial tyrosyl-tRNA synthetase 2 (YARS2) and the 7511A>G mutation in tRNASer(UCN)caused hearing loss [102]. Moreover, in the study of Chinese families, people who suffer both mutations present much higher penetrance of hearing loss than those who carry only one [102]. Mtu1 is a tRNA-modifying enzyme and mtu1 knockout zebrafish exhibited a smaller number of hair cells and reductions in the hair bundle densities in the auditory and vestibular organs [103]. Deletion of Gtpbp3 also resulted in impairment of mitochondria function in zebrafish, which provided novel opportunities for studying pathophysiology of mitochondrial disorders [104].
Much more mitochondrial gene loci associated with hearing loss have been discovered due to advanced technology. Mitochondrial dysfunction caused by mtDNA mutations are one of the major molecular mechanisms responsible for deafness. However, many cases remained unclear. We hope more research will be carried out in the future.
3. Sirtuins and Function
Sirtuins were originally described in yeast and named Sir2, with seven Sir2 homologs (SIRT1-7) discovered. Sirtuins consume NAD+ to deacetylate lysine residues and generate nicotinamide and 2′-O-acetyl-ADP-ribose [105]. The crucial function of sirtuins is to sense and regulate cellular metabolic responses [106, 107]. They display diverse subcellular localizations in the cell. In the nucleus, there are mainly SIRT1, SIRT6, and SIRT7, whereas in the cytoplasm, SIRT2 is located. SIRT3, SIRT4, and SIRT5 are predominantly located in the mitochondria [16] and are the main focus of this review. SIRT3 is the principal mitochondrial deacetylase, whereas SIRT4 and SIRT5 only have weak deacetylase functions [108]. However, SIRT5 has robust demalonylase, desuccinylase, and deglutarylase activities [109], and SIRT4 can regulate lipoamidation [110].
3.1. SIRT3
SIRT3 is the main deacetylase in mitochondria, and its expression is the highest in tissues with vigorous metabolism such as the liver, kidney, and heart [111]. SIRT3 level increases under calorie restriction, fasting, and exercise training in different tissues [112, 113]. Acetyl-CoA synthetase 2 was the first reported target of SIRT3 [114]. However, further research revealed that SIRT3 also affected a diverse range of target proteins and participated in all major biochemical reactions and metabolic activities of mitochondria, including the respiratory chain, antioxidant defenses, and apoptosis [15, 16].
SIRT3 is an important factor involved in resisting various mitochondrial stresses, especially by utilizing cellular antioxidant systems to combat oxidative stress. SOD2, which reduces ROS levels and protects against oxidative stress, is activated by SIRT3-mediated deacetylation [115]. SIRT3 deacetylates and activates IDH2, the major source of NADPH in mitochondria, which helps maintain GSH levels [16, 15, 116]. Deacetylation of FOXO3A, a forkhead transcription factor, by SIRT3 activates the transcription of SOD2, catalase, and other crucial antioxidant genes and protects mitochondria from further oxidative stress [117, 118]. Another key stress-sensitive pathway in mitochondria affected by SIRT3 is the mitochondrial permeability transition pore. SIRT3 deacetylates cyclophilin D [119] and mitochondrial fusion protein optic atrophy protein 1. These proteins affect mitochondrial dynamics and the MMP [120].
SIRT3 plays important roles in a wide range of diseases, including hearing loss. As mentioned above, ROS and mitochondrial dysfunction have much to do with the etiology of SNHL. SIRT3 deacetylates and activates the antioxidant system in mitochondria to reduce the level of ROS induced by noise, aging, or drugs and maintain mitochondrial permeability through deacetylation of proteins. Under caloric restriction, deacetylation and activation of IDH2 by SIRT3 increased the levels of NADPH and GSH in mitochondria, thus preventing ARHL in wild-type, but not SIRT3-knockout mice [112]. Similarly, overexpression of SIRT3 in mice aided in preventing NIHL. Administration of the NAD+ precursor nicotinamide riboside to mice prevented the degeneration of spiral ganglia neurites and NIHL by activating the NAD+-SIRT3 pathway, and these protective effects were abrogated with SIRT3 deletion [121]. Adjudin, a lonidamine analog, could protect cochlear HCs from gentamicin-induced damage mediated by the SIRT3-ROS axis [122].
3.2. SIRT4
SIRT4 is widely expressed and abundant in pancreatic β-cells, kidney, heart, brain, and liver [123, 110]. It has been reported that SIRT4 has no detectable NAD+-dependent deacetylase activity and function through NAD+-dependent ADP-ribosylation [16, 123]. Few studies have been carried out in other tissues, except pancreatic ß-cells, and the precise enzymatic functions of SIRT4 remain unclear. ATP is indispensable for insulin secretion by pancreatic β-cells, and SIRT4 inhibits the activity of glutamate dehydrogenase (GDH) to reduce the amount of ATP produced by the catabolism of glutamate and glutamine [124, 16]. Mice deficient in SIRT4 or subjected to calorie restriction exhibited upregulation of amino acid-stimulated insulin secretion [123]. It is interesting that SIRT3 deacetylates and activates GDH, indicating that this enzyme may be regulated by both SIRT3 and SIRT4 [124, 125]. SIRT4 knockdown also caused increased fatty acid oxidation dependent on SIRT1, respiration, and AMPK phosphorylation [126].
Compared with those on SIRT3, there have been fewer studies on the regulation of SIRT4. Recent research suggests that SIRT4 may be involved in ROS homeostasis by the pyruvate dehydrogenase complex and GDH and fatty acid oxidation through malonyl-CoA decarboxylase [110, 127], ultimately reducing ROS production, that is, may have potentially optimistic effect in preservation of hearing function. However, there are studies showing that increased activity of SIRT4 may raise ROS levels in murine cardiomyocytes [128, 129]. Nevertheless, the precise mechanism of SIRT4 enzymatic activity is unknown, though it may play a role in hearing loss. Further studies are needed to identify the mechanism underlying SIRT4 function.
3.3. SIRT5
Unlike other sirtuins, SIRT5 primarily originated from prokaryotes [130], with high expression in various tissues such as the heart, brain, and liver. [131]. The function of SIRT5 has generally become an important research topic.
SIRT5-deficient mice show no detectable alterations in the whole acetylation state of mitochondria, indicating there is a specific acetyl substrate for SIRT5 or alternative functions [132]. And global protein hypermalonylation and hypersuccinylation are observed, indicating that SIRT5 catalyzes lysine demalonylation and desuccinylation reactions in mammals [133]. One target of SIRT5 is carbamoyl phosphate synthetase 1 (CPS1). This enzyme has been identified as the key rate-determining step of the urea cycle for detoxification and removal of ammonia. SIRT5 upregulates CPS1 activity through deacetylation and desuccinylation, and this function is absent in SIRT5-deficient mice [124, 134, 15]. In mice overexpressing SIRT5, the CPS1 protein was more deacetylated and activated in the liver than in wild-type mice [135].
In terms of occurrence and development of SNHL, SIRT5 has been demonstrated to contribute to ROS homeostasis and attenuate oxidative stress. It may reduce ROS levels and oxidative stress through a mechanism similar to that of SIRT3, by deacetylation of FOXO3A and desuccinylation of IDH2, so that it may have optimistic effect on preserve hearing function [136, 137]. Another study showed that SIRT5 enhanced SOD1-mediated ROS reduction by desuccinylation [138]. Recent evidence suggests that SIRT5 plays a potential protective role against neurodegeneration, which is a common phenomenon in SNHL. Although the mechanism remains undetermined, SIRT5 may protect neurons by limiting overproduction of ROS directly and controlling systemic ammonia levels indirectly [139].
4. Conclusion
Although extensive research is required to probe the pathology of hearing loss, a causative role for mitochondrial dysfunction remains one of the most solid theories. Mitochondrial sirtuins (SIRT3-5) are intimately linked to responses to stress, such as oxidative stress, metabolic regulation, and apoptosis, all of which are related to the occurrence and development of hearing loss. Moreover, we have reasons to believe SIRT3-5 have positive effect on SNHL. Moving forward, it is important to determine the precise activities of mitochondrial sirtuins as crucial targets to help prevent and cure hearing loss.
Data Availability
The data that support the findings of this study are openly available from the corresponding author upon reasonable request.
Conflicts of Interest
The authors declare that there is no conflict of interests regarding the publication of this paper.
Acknowledgments
We would like to thank all the authors who contributed to this special issue. This work was supported by grants from the National Natural Science Foundation of China (Grant Nos. 81830030, 81771016, and 81700917).
VosT.AllenC.AroraM.BarberR. M.BhuttaZ. A.BrownA.CarterA.CaseyD. C.CharlsonF. J.ChenA. Z.CoggeshallM.CornabyL.DandonaL.DickerD. J.DileggeT.ErskineH. E.FerrariA. J.FitzmauriceC.FlemingT.ForouzanfarM. H.FullmanN.GethingP. W.GoldbergE. M.GraetzN.HaagsmaJ. A.HayS. I.JohnsonC. O.KassebaumN. J.KawashimaT.KemmerL.KhalilI. A.KinfuY.KyuH. H.LeungJ.LiangX.LimS. S.LopezA. D.LozanoR.MarczakL.MensahG. A.MokdadA. H.NaghaviM.NguyenG.NsoesieE.OlsenH.PigottD. M.PinhoC.RankinZ.ReinigN.SalomonJ. A.SandarL.SmithA.StanawayJ.SteinerC.TeepleS.ThomasB. A.TroegerC.WagnerJ. A.WangH.WangaV.WhitefordH. A.ZoecklerL.AbajobirA. A.AbateK. H.AbbafatiC.AbbasK. M.Abd-AllahF.AbrahamB.AbubakarI.Abu-RaddadL. J.Abu-RmeilehN. M. E.AckermanI. N.AdebiyiA. O.AdemiZ.AdouA. K.AfanviK. A.AgardhE. E.AgarwalA.KiadaliriA. A.AhmadiehH.AjalaO. N.AkinyemiR. O.AkseerN.al-AlyZ.AlamK.AlamN. K. M.AldhahriS. F.AlegrettiM. A.AlemuZ. A.AlexanderL. T.AlhabibS.AliR.AlkerwiA.AllaF.AllebeckP.al-RaddadiR.AlsharifU.AltirkawiK. A.Alvis-GuzmanN.AmareA. T.AmberbirA.AminiH.AmmarW.AmrockS. M.AndersenH. H.AndersonG. M.AndersonB. O.AntonioC. A. T.AregayA. F.ÄrnlövJ.Al ArtamanH. A.AsayeshH.AssadiR.AtiqueS.AvokpahoE. F. G. A.AwasthiA.QuintanillaB. P. A.AzzopardiP.BachaU.BadawiA.BalakrishnanK.BanerjeeA.BaracA.Barker-ColloS. L.BärnighausenT.BarregardL.BarreroL. H.BasuA.Bazargan-HejaziS.BeghiE.BellM. L.BellM. L.BennettD. A.BensenorI. M.BenzianH.BerhaneA.BernabéE.BetsuB. D.BeyeneA. S.BhalaN.BhattS.BiadgilignS.BienhoffK.BikbovB.BiryukovS.BisanzioD.BjertnessE.BloreJ.BorschmannR.BoufousS.BraininM.BrazinovaA.BreitbordeN. J. K.BrownJ.BuchbinderR.BuckleG. C.ButtZ. A.CalabriaB.Campos-NonatoI. R.CampuzanoJ. C.CarabinH.CárdenasR.CarpenterD. O.CarreroJ. J.Castañeda-OrjuelaC. A.RivasJ. C.Catalá-LópezF.ChangJ.-C.ChiangP. P.-C.ChibuezeC. E.ChisumpaV. H.ChoiJ.-Y. J.ChowdhuryR.ChristensenH.ChristopherD. J.CiobanuL. G.CirilloM.CoatesM. M.ColquhounS. M.CooperC.CortinovisM.CrumpJ. A.DamtewS. A.DandonaR.DaoudF.DarganP. I.das NevesJ.DaveyG.DavisA. C.LeoD. D.DegenhardtL.GobboL. C. D.DellavalleR. P.DeribeK.DeribewA.DerrettS.JarlaisD. C. D.DharmaratneS. D.DhillonP. K.Diaz-TornéC.DingE. L.DriscollT. R.DuanL.DubeyM.DuncanB. B.EbrahimiH.EllenbogenR. G.ElyazarI.EndresM.EndriesA. Y.ErmakovS. P.EshratiB.EstepK.FaridT. A.FarinhaC. S. e. S.FaroA.FarvidM. S.FarzadfarF.FeiginV. L.FelsonD. T.FereshtehnejadS.-M.FernandesJ. C.FernandesJ. C.FischerF.FitchettJ. R. A.ForemanK.FowkesF. G. R.FoxJ.FranklinR. C.FriedmanJ.FrostadJ.FürstT.FutranN. D.GabbeB.GangulyP.GankpéF. G.GebreT.GebrehiwotT. T.GebremedhinA. T.GeleijnseJ. M.GessnerB. D.GibneyK. B.GinawiI. A. M.GirefA. Z.GiroudM.GishuM. D.GiussaniG.GlaserE.GodwinW. W.Gomez-DantesH.GonaP.GoodridgeA.GopalaniS. V.GotayC. C.GotoA.GoudaH. N.GraingerR.GreavesF.GuilleminF.GuoY.GuptaR.GuptaV.GuptaV.GutiérrezR. A.HaileD.HailuG. B.HailuG. B.HalasaY. A.HamadehR. R.HamidiS.HammamiM.HancockJ.HandalA. J.HankeyG. J.HaoY.HarbH. L.HarikrishnanS.HaroJ. M.HavmoellerR.HayR. J.Heredia-PiI. B.HeydarpourP.HoekH. W.HorinoM.HoritaN.HosgoodH. D.HoyD. G.HtetA. S.HuangJ. J.HuangJ. J.HuynhC.IannaroneM.IburgK. M.InnosK.InoueM.IyerV. J.JacobsenK. H.JahanmehrN.JakovljevicM. B.JavanbakhtM.JayaramanS. P.JayatillekeA. U.JeeS. H.JeemonP.JensenP. N.JiangY.JibatT.Jimenez-CoronaA.JinY.JonasJ. B.KabirZ.KalkondeY.KamalR.KanH.KarchA.KaremaC. K.KarimkhaniC.KasaeianA.KaulA.KawakamiN.KeiyoroP. N.KempA. H.KerenA.KesavachandranC. N.KhaderY. S.KhanE. A.KhanE. A.KhangY.-H.KheraS.KhojaT. A. M.KhubchandaniJ.KielingC.KimC.-i.KimD.KimY. J.KimY. J.KissoonN.KnibbsL. D.KnudsenA. K.KokuboY.KolteD.KopecJ. A.KosenS.KotsakisG. A.KoulP. A.KoyanagiA.KravchenkoM.DefoB. K.BicerB. K.KudomA. A.KuipersE. J.KumarG. A.KutzM.KwanG. F.LalA.LallooR.LallukkaT.LamJ. O.LamJ. O.LanganS. M.LarssonA.LavadosP. M.LeasherJ. L.LeighJ.LeungR.LeviM.LiY.LiY.LiangJ.LiuY.LiuY.LloydB. K.LoW. D.LogroscinoG.LookerK. J.LotufoP. A.LuneviciusR.LyonsR. A.MackayM. T.MagdyM.RazekA. E.MahdaviM.MajdanM.MajeedA.MalekzadehR.MarcenesW.MargolisD. J.Martinez-RagaJ.MasiyeF.MassanoJ.McGarveyS. T.McGrathJ. J.McKeeM.McMahonB. J.MeaneyP. A.MehariA.Mejia-RodriguezF.MekonnenA. B.MelakuY. A.MemiahP.MemishZ. A.MendozaW.MeretojaT. J.MeretojaT. J.MhimbiraF. A.MillearA.MillerT. R.MillsE. J.MirarefinM.MitchellP. B.MockC. N.MohammadiA.MohammedS.MonastaL.HernandezJ. C. M.MonticoM.MooneyM. D.Moradi-LakehM.MorawskaL.MuellerU. O.MullanyE.MumfordJ. E.MurdochM. E.NachegaJ. B.NagelG.NaheedA.NaldiL.NangiaV.NewtonJ. N.NgM.NgalesoniF. N.NguyenQ. L.NisarM. I.PeteP. M. N.NollaJ. M.NorheimO. F.NormanR. E.NorrvingB.NunesB. P.OgboF. A.OhI.-H.OhkuboT.OlivaresP. R.OlusanyaJ. O.OlusanyaJ. O.OrtizA.OsmanM.OtaE.PAM.ParkE. K.ParsaeianM.de Azeredo PassosV. M.CaicedoA. J. P.PattenS. B.PattonG. C.PereiraD. M.Perez-PadillaR.PericoN.PesudovsK.PetzoldM.PhillipsM. R.PielF. B.PillayJ. D.PishgarF.PlassD.Platts-MillsJ. A.PolinderS.PondC. D.PopovaS.PoultonR. G.PourmalekF.PrabhakaranD.PrasadN. M.QorbaniM.RabieeR. H. S.RadfarA.RafayA.RahimiK.Rahimi-MovagharV.RahmanM. H. U.RahmanS. U.RahmanS. U.RaiR. K.RajsicS.RamU.RaoP.RefaatA. H.ReitsmaM. B.RemuzziG.ResnikoffS.ReynoldsA.RibeiroA. L.BlancasM. J. R.RobaH. S.Rojas-RuedaD.RonfaniL.RoshandelG.RothG. A.RothenbacherD.RoyA.SagarR.SahathevanR.SanabriaJ. R.Sanchez-NiñoM. D.SantosJ. V.SantosJ. V.Sarmiento-SuarezR.SartoriusB.SatpathyM.SavicM.SawhneyM.SchaubM. P.SchmidtM. I.SchneiderI. J. C.SchöttkerB.SchwebelD. C.ScottJ. G.SeedatS.SepanlouS. G.Servan-MoriE. E.ShackelfordK. A.ShaheenA.ShaikhM. A.SharmaU.SharmaU.ShenJ.ShepardD. S.ShethK. N.ShibuyaK.ShinM. J.ShiriR.ShiueI.ShrimeM. G.SigfusdottirI. D.SilvaD. A. S.SilveiraD. G. A.SinghJ. A.SinghO. P.SinghP. K.SinghP. K.SivondaA.SkirbekkV.SkogenJ. C.SligarA.SliwaK.SoljakM.SøreideK.SorensenR. J. D.SorianoJ. B.SposatoL. A.SreeramareddyC. T.StathopoulouV.SteelN.SteinD. J.SteinerT. J.SteinkeS.StovnerL.StroumpoulisK.SunguyaB. F.SurP.SwaminathanS.SykesB. L.SzoekeC. E. I.Tabarés-SeisdedosR.TakalaJ. S.TandonN.TanneD.TavakkoliM.TayeB.TaylorH. R.AoB. J. T.TedlaB. A.TerkawiA. S.ThomsonA. J.Thorne-LymanA. L.ThriftA. G.ThurstonG. D.Tobe-GaiR.TonelliM.Topor-MadryR.TopouzisF.TranB. X.TruelsenT.DimbueneZ. T.TsilimbarisM.TuraA. K.TuzcuE. M.TyrovolasS.UkwajaK. N.UndurragaE. A.UnekeC. J.UthmanO. A.van GoolC. H.VarakinY. Y.VasankariT.VenketasubramanianN.VermaR. K.ViolanteF. S.VladimirovS. K.VlassovV. V.VollsetS. E.WagnerG. R.WallerS. G.WangL.WatkinsD. A.WeichenthalS.WeiderpassE.WeintraubR. G.WerdeckerA.WestermanR.WhiteR. A.WilliamsH. C.WiysongeC. S.WolfeC. D. A.WonS.WoodbrookR.WubshetM.XavierD.XuG.YadavA. K.YanL. L.YanoY.YaseriM.YeP.YebyoH. G.YipP.YonemotoN.YoonS. J.YounisM. Z.YuC.ZaidiZ.ZakiM. E. S.ZeebH.ZhouM.ZodpeyS.ZuhlkeL. J.MurrayC. J. L.Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 20152016388100531545160210.1016/S0140-6736(16)31678-62-s2.0-8499409204927733282CunninghamL. L.TucciD. L.Hearing loss in adults2017377252465247310.1056/NEJMra16166012-s2.0-8503978753829262274NiemanC. L.OhE. S.Hearing loss202017311ITC81ITC9610.7326/AITC20201201033253610ZhouH.QianX.XuN.ZhangS.ZhuG.ZhangY.LiuD.ChengC.ZhuX.LiuY.LuL.TangJ.ChaiR.GaoX.Disruption of Atg7-dependent autophagy causes electromotility disturbances, outer hair cell loss, and deafness in mice2020111091310.1038/s41419-020-03110-833099575TurrensJ. F.Mitochondrial formation of reactive oxygen species2003552233534410.1113/jphysiol.2003.0494782-s2.0-014215005114561818BalabanR. S.NemotoS.FinkelT.Mitochondria, oxidants, and aging2005120448349510.1016/j.cell.2005.02.0012-s2.0-1394427813215734681BonawitzN. D.RodehefferM. S.ShadelG. S.Defective mitochondrial gene expression results in reactive oxygen species-mediated inhibition of respiration and reduction of yeast life span200626134818482910.1128/MCB.02360-052-s2.0-3374547335116782871WangT.ChaiR.KimG. S.PhamN.JanssonL.NguyenD.-H.KuoB.MayL. A.ZuoJ.CunninghamL. L.ChengA. G.Lgr5+ cells regenerate hair cells via proliferation and direct transdifferentiation in damaged neonatal mouse utricle20156110.1038/ncomms76132-s2.0-84926674987ZhangS.ZhangY.DongY.GuoL.ZhangZ.ShaoB.QiJ.ZhouH.ZhuW.YanX.HongG.ZhangL.ZhangX.TangM.ZhaoC.GaoX.ChaiR.Knockdown of Foxg1 in supporting cells increases the trans-differentiation of supporting cells into hair cells in the neonatal mouse cochlea20207771401141910.1007/s00018-019-03291-22-s2.0-8507176728031485717ZhangY.ZhangS.ZhangZ.DongY.MaX.QiangR.ChenY.GaoX.ZhaoC.ChenF.HeS.ChaiR.Knockdown of Foxg1 in Sox9+ supporting cells increases the trans-differentiation of supporting cells into hair cells in the neonatal mouse utricle20201220198341985110.18632/aging.10400933099273ZhangS.LiuD.DongY.ZhangZ.ZhangY.ZhouH.GuoL.QiJ.QiangR.TangM.GaoX.ZhaoC.ChenX.QianX.ChaiR.Frizzled-9+ supporting cells are progenitors for the generation of hair cells in the postnatal mouse cochlea20191210.3389/fnmol.2019.001842-s2.0-85072738034GuoR.MaX.LiaoM.LiuY.HuY.QianX.TangQ.GuoX.ChaiR.GaoX.TangM.Development and application of cochlear implant-based electric-acoustic stimulation of spiral ganglion neurons20195126735674110.1021/acsbiomaterials.9b0126533423491ZhangS.QiangR.DongY.ZhangY.ChenY.ZhouH.GaoX.ChaiR.Hair cell regeneration from inner ear progenitors in the mammalian cochlea202093TuerdiA.KinoshitaM.KamogashiraT.FujimotoC.IwasakiS.ShimizuT.YamasobaT.Manganese superoxide dismutase influences the extent of noise-induced hearing loss in mice201764212312810.1016/j.neulet.2017.02.0032-s2.0-8501205083228163078OsborneB.BentleyN. L.MontgomeryM. K.TurnerN.The role of mitochondrial sirtuins in health and disease201610016417410.1016/j.freeradbiomed.2016.04.1972-s2.0-8496952893927164052HeW.NewmanJ. C.WangM. Z.HoL.VerdinE.Mitochondrial sirtuins: regulators of protein acylation and metabolism201223946747610.1016/j.tem.2012.07.0042-s2.0-84865421953SomeyaS.YamasobaT.WeindruchR.ProllaT. A.TanokuraM.Caloric restriction suppresses apoptotic cell death in the mammalian cochlea and leads to prevention of presbycusis200728101613162210.1016/j.neurobiolaging.2006.06.0242-s2.0-3454779748316890326KnipperM.Van DijkP.NunesI.RüttigerL.ZimmermannU.Advances in the neurobiology of hearing disorders: recent developments regarding the basis of tinnitus and hyperacusis2013111173310.1016/j.pneurobio.2013.08.0022-s2.0-8488813557224012803ChengC.WangY.GuoL.LuX.ZhuW.MuhammadW.ZhangL.LuL.GaoJ.TangM.ChenF.GaoX.LiH.ChaiR.Age-related transcriptome changes in Sox2+ supporting cells in the mouse cochlea201910136510.1186/s13287-019-1437-031791390DuZ.-D.YuS.QiY.QuT.-F.HeL.WeiW.LiuK.GongS.-S.NADPH oxidase inhibitor apocynin decreases mitochondrial dysfunction and apoptosis in the ventral cochlear nucleus of D-galactose-induced aging model in rats2019124314010.1016/j.neuint.2018.12.0082-s2.0-8505897310830578839KeithleyE. M.CantoC.ZhengQ. Y.Fischel-GhodsianN.JohnsonK. R.Age-related hearing loss and the ahl locus in mice20041881-2212810.1016/S0378-5955(03)00365-42-s2.0-084232674314759567LiuY.QiJ.ChenX.TangM.ChuC.ZhuW.LiH.TianC.YangG.ZhongC.ZhangY.NiG.HeS.ChaiR.ZhongG.Critical role of spectrin in hearing development and deafness201954, article eaav780310.1126/sciadv.aav78032-s2.0-8506470309331001589HeZ.-h.ZouS.-y.LiM.LiaoF.-l.WuX.SunH.-y.ZhaoX.-y.HuY.-j.LiD.XuX.-x.ChenS.SunY.ChaiR.-j.KongW.-j.The nuclear transcription factor FoxG1 affects the sensitivity of mimetic aging hair cells to inflammation by regulating autophagy pathways20202810136410.1016/j.redox.2019.101364FuX.SunX.ZhangL.JinY.ChaiR.YangL.ZhangA.LiuX.BaiX.LiJ.WangH.GaoJ.Tuberous sclerosis complex-mediated mTORC1 overactivation promotes age-related hearing loss2018128114938495510.1172/JCI980582-s2.0-8505582438730247156DingY.MengW.KongW.HeZ.ChaiR.The role of FoxG1 in the inner ear20208, article 61495410.3389/fcell.2020.614954DuZ.-D.HanS.-G.QuT.-F.GuoB.YuS.-K.WeiW.FengS.LiuK.GongS.-S.Age-related insult of cochlear ribbon synapses: an early-onset contributor to D-galactose-induced aging in mice2020133, article 10464910.1016/j.neuint.2019.104649LinnaneA. W.OzawaT.MarzukiS.TanakaM.Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases1989333863964264510.1016/S0140-6736(89)92145-42-s2.0-0024541837KamogashiraT.FujimotoC.YamasobaT.Reactive oxygen species, apoptosis, and mitochondrial dysfunction in hearing loss20152015761720710.1155/2015/6172072-s2.0-8492715357525874222CrawleyB. K.KeithleyE. M.Effects of mitochondrial mutations on hearing and cochlear pathology with age20112801-220120810.1016/j.heares.2011.05.0152-s2.0-8005305253921664445SomeyaS.YamasobaT.KujothG. C.PughT. D.WeindruchR.TanokuraM.ProllaT. A.The role of mtDNA mutations in the pathogenesis of age-related hearing loss in mice carrying a mutator DNA polymerase γ20082971080109210.1016/j.neurobiolaging.2007.01.0142-s2.0-4384910809317363114MenardoJ.TangY.LadrechS.LenoirM.CasasF.MichelC.BourienJ.RuelJ.RebillardG.MauriceT.PuelJ.-L.WangJ.Oxidative stress, inflammation, and autophagic stress as the key mechanisms of premature age-related hearing loss in SAMP8 mouse cochlea201216326327410.1089/ars.2011.40372-s2.0-8325518437621923553TanrıkuluS.Doğru-AbbasoğluS.ÖzderyaA.AdemoğluE.KaradağB.ErbilY.UysalM.The 8-oxoguanine DNA N-glycosylase 1 (hOGG1) Ser326Cys variant affects the susceptibility to Graves' disease201129324424810.1002/cbf.17422-s2.0-7995374284221465496KamogashiraT.HayashiK.FujimotoC.IwasakiS.YamasobaT.Functionally and morphologically damaged mitochondria observed in auditory cells under senescence-inducing stress201731210.1038/s41514-017-0002-22-s2.0-8504986883928649420FujimotoC.YamasobaT.Oxidative stresses and mitochondrial dysfunction in age-related hearing loss20142014658284910.1155/2014/5828492-s2.0-8490468826425110550SomeyaS.XuJ.KondoK.DingD.SalviR. J.YamasobaT.RabinovitchP. S.WeindruchR.LeeuwenburghC.TanokuraM.ProllaT. A.Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis200910646194321943710.1073/pnas.09087861062-s2.0-7334910952419901338WhiteK.KimM.-J.HanC.ParkH.-J.DingD.BoydK.WalkerL.LinserP.MenesesZ.SladeC.HirstJ.SantostefanoK.TeradaN.MiyakawaT.TanokuraM.SalviR.SomeyaS.Loss of IDH2 accelerates age-related hearing loss in male mice201881503910.1038/s41598-018-23436-w2-s2.0-8504437099529567975KeithleyE. M.CantoC.ZhengQ. Y.WangX.Fischel-GhodsianN.JohnsonK. R.Cu/Zn superoxide dismutase and age-related hearing loss20052091-2768510.1016/j.heares.2005.06.0092-s2.0-2764450691016055286DingD.JiangH.ChenG.-D.Longo-GuessC.MuthaiahV. P. K.TianC.SheppardA.SalviR.JohnsonK. R.N-acetyl-cysteine prevents age-related hearing loss and the progressive loss of inner hair cells in γ-glutamyl transferase 1 deficient mice20168473075010.18632/aging.1009272-s2.0-8501713806126977590BenkafadarN.FrançoisF.AffortitC.CasasF.CeccatoJ.-C.MenardoJ.VenailF.Malfroy-CamineB.PuelJ.-L.WangJ.ROS-induced activation of DNA damage responses drives senescence-like state in postmitotic cochlear cells: implication for hearing preservation20195685950596910.1007/s12035-019-1493-62-s2.0-8506102990130693443St-PierreJ.DroriS.UldryM.SilvaggiJ. M.RheeJ.JägerS.HandschinC.ZhengK.LinJ.YangW.SimonD. K.BachooR.SpiegelmanB. M.Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators2006127239740810.1016/j.cell.2006.09.0242-s2.0-3374999953017055439MerksamerP. I.LiuY.HeW.HirscheyM. D.ChenD.VerdinE.The sirtuins, oxidative stress and aging: an emerging link20135314415010.18632/aging.1005442-s2.0-8487764218723474711ZhaoX.-Y.SunJ.-L.HuY.-J.YangY.ZhangW.-J.HuY.LiJ.SunY.ZhongY.PengW.ZhangH.-L.KongW.-J.The effect of overexpression of PGC-1α on the mtDNA4834 common deletion in a rat cochlear marginal cell senescence model2013296132410.1016/j.heares.2012.11.0072-s2.0-8487525910723159434FujimotoC.YamasobaT.Mitochondria-targeted antioxidants for treatment of hearing loss: a systematic review20198410910.3390/antiox80401092-s2.0-8506703365631022870FetoniA. R.PacielloF.RolesiR.PaludettiG.TroianiD.Targeting dysregulation of redox homeostasis in noise-induced hearing loss: oxidative stress and ROS signaling2019135465910.1016/j.freeradbiomed.2019.02.0222-s2.0-8506223066830802489HongO. S.KerrM. J.PolingG. L.DharS.Understanding and preventing noise-induced hearing loss201359411011810.1016/j.disamonth.2013.01.0022-s2.0-8487535798923507351VlajkovicS. M.LeeK.-H.WongA. C. Y.GuoC. X.GuptaR.HousleyG. D.ThorneP. R.Adenosine amine congener mitigates noise-induced cochlear injury20106227328110.1007/s11302-010-9188-52-s2.0-7795517384720806018MillerJ. M.BrownJ. N.SchachtJ.8-iso-prostaglandin F(2alpha), a product of noise exposure, reduces inner ear blood flow20038420722110.1159/0000710612-s2.0-003797111912811002OhlemillerK. K.McFaddenS. L.DingD.-L.LearP. M.HoY.-S.Targeted mutation of the gene for cellular glutathione peroxidase (Gpx1) increases noise-induced hearing loss in mice20001324325410.1007/s1016200100432-s2.0-003445020611545230FridbergerA.FlockA.UlfendahlM.FlockB.Acoustic overstimulation increases outer hair cell Ca2+ concentrations and causes dynamic contractions of the hearing organ199895127127713210.1073/pnas.95.12.71272-s2.0-00324997159618550KurabiA.KeithleyE. M.HousleyG. D.RyanA. F.WongA. C.-Y.Cellular mechanisms of noise-induced hearing loss201734912913710.1016/j.heares.2016.11.0132-s2.0-8500836776827916698WangX.ZhuY.LongH.PanS.XiongH.FangQ.HillK.LaiR.YuanH.ShaS.-H.Mitochondrial calcium transporters mediate sensitivity to noise-induced losses of hair cells and cochlear synapses20191110.3389/fnmol.2018.004692-s2.0-85064232917LeT. N.StraatmanL. V.LeaJ.WesterbergB.Current insights in noise-induced hearing loss: a literature review of the underlying mechanism, pathophysiology, asymmetry, and management options20174614110.1186/s40463-017-0219-x2-s2.0-8501987920328535812OrreniusS.ZhivotovskyB.NicoteraP.Regulation of cell death: the calcium-apoptosis link20034755256510.1038/nrm11502-s2.0-003846465012838338NagashimaR.YamaguchiT.KuramotoN.OgitaK.Acoustic overstimulation activates 5′-AMP-activated protein kinase through a temporary decrease in ATP level in the cochlear spiral ligament prior to permanent hearing loss in mice201159681282010.1016/j.neuint.2011.08.0152-s2.0-8005317624121906645TaitS. W.GreenD. R.Caspase-independent cell death: leaving the set without the final cut200827506452646110.1038/onc.2008.3112-s2.0-5494915271618955972SchachtJ.TalaskaA. E.RybakL. P.Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention2012295111837185010.1002/ar.225782-s2.0-8486789689823045231LiH.SongY.HeZ.ChenX.WuX.LiX.BaiX.LiuW.LiB.WangS.HanY.XuL.ZhangD.LiJ.ChaiR.WangH.FanZ.Meclofenamic acid reduces reactive oxygen species accumulation and apoptosis, inhibits excessive autophagy, and protects hair cell-like HEI-OC1 cells from cisplatin-induced damage20181213910.3389/fncel.2018.001392-s2.0-85048947790LiuW.XuX.FanZ.SunG.HanY.ZhangD.XuL.WangM.WangX.ZhangS.TangM.LiJ.ChaiR.WangH.Wnt signaling activates TP53-induced glycolysis and apoptosis regulator and protects against cisplatin-induced spiral ganglion neuron damage in the mouse cochlea201930111389141010.1089/ars.2017.72882-s2.0-8506227763029587485JiangM.KarasawaT.SteygerP. S.Aminoglycoside-induced cochleotoxicity: a review20171130810.3389/fncel.2017.003082-s2.0-85032003199ZhongZ.FuX.LiH.ChenJ.WangM.GaoS.ZhangL.ChengC.ZhangY.LiP.ZhangS.QianX.ShuY.ChaiR.GaoX.Citicoline protects auditory hair cells against neomycin-induced damage2020810.3389/fcell.2020.00712GaoS.ChengC.WangM.JiangP.ZhangL.WangY.WuH.ZengX.WangH.GaoX.MaY.ChaiR.Blebbistatin inhibits neomycin-induced apoptosis in hair cell-like HEI-OC-1 cells and in cochlear hair cells20201310.3389/fncel.2019.00590HeZ.GuoL.ShuY.FangQ.ZhouH.LiuY.LiuD.LuL.ZhangX.DingX.LiuD.TangM.KongW.ShaS.LiH.GaoX.ChaiR.Autophagy protects auditory hair cells against neomycin-induced damage201713111884190410.1080/15548627.2017.13594492-s2.0-8503975993528968134HeZ.FangQ.LiH.ShaoB.ZhangY.ZhangY.HanX.GuoR.ChengC.GuoL.ShiL.LiA.YuC.KongW.ZhaoC.GaoX.ChaiR.The role of FOXG1 in the postnatal development and survival of mouse cochlear hair cells2019144435710.1016/j.neuropharm.2018.10.0212-s2.0-8505619915930336149ZhangY.LiW.HeZ.WangY.ShaoB.ChengC.ZhangS.TangM.QianX.KongW.WangH.ChaiR.GaoX.Pre-treatment with fasudil prevents neomycin-induced hair cell damage by reducing the accumulation of reactive oxygen species20191226410.3389/fnmol.2019.00264NguyenT.JeyakumarA.Genetic susceptibility to aminoglycoside ototoxicity2019120151910.1016/j.ijporl.2019.02.0022-s2.0-8506121338530743189GaoZ.ChenY.GuanM. X.Mitochondrial DNA mutations associated with aminoglycoside induced ototoxicity20171211810.1016/j.joto.2017.02.0012-s2.0-8504433627029937831ZhaoH.LiR.WangQ.YanQ.DengJ.-H.HanD.BaiY.YoungW.-Y.GuanM.-X.Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family200474113915210.1086/3811332-s2.0-034700351214681830HanD.DaiP.ZhuQ.LiuX.HuangD.YuanY.YuanH.WangX.QianY.YoungW.-Y.GuanM.-X.The mitochondrial tRNAAla T5628C variant may have a modifying role in the phenotypic manifestation of the 12S rRNA C1494T mutation in a large Chinese family with hearing loss2007357255456010.1016/j.bbrc.2007.03.1992-s2.0-3424709854317434445WangQ.LiQ.-Z.HanD.ZhaoY.ZhaoL.QianY.YuanH.LiR.ZhaiS.YoungW.-Y.GuanM.-X.Clinical and molecular analysis of a four-generation Chinese family with aminoglycoside-induced and nonsyndromic hearing loss associated with the mitochondrial 12S rRNA C1494T mutation2006340258358810.1016/j.bbrc.2005.12.0452-s2.0-2964444646416380089the CPNDS ConsortiumRossC. J. D.Katzov-EckertH.DubéM.-P.BrooksB.RassekhS. R.BarhdadiA.Feroz-ZadaY.VisscherH.BrownA. M. K.RiederM. J.RogersP. C.PhillipsM. S.CarletonB. C.HaydenM. R.Genetic variants in TPMT and _COMT_ are associated with hearing loss in children receiving cisplatin chemotherapy200941121345134910.1038/ng.4782-s2.0-70649113052YangJ. J.LimJ. Y. S.HuangJ.BassJ.WuJ.WangC.FangJ.StewartE.HarsteadE. H.ES.RobinsonG. W.EvansW. E.PappoA.ZuoJ.RellingM. V.Onar-ThomasA.GajjarA.StewartC. F.The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer201394225225910.1038/clpt.2013.1212-s2.0-8488075347723820299QiJ.ZhangL.TanF.LiuY.ChuC.ZhuW.WangY.QiZ.ChaiR.Espin distribution as revealed by super-resolution microscopy of stereocilia2020121QiJ.LiuY.ChuC.ChenX.ZhuW.ShuY.HeS.ChaiR.ZhongG.A cytoskeleton structure revealed by super-resolution fluorescence imaging in inner ear hair cells20195110.1038/s41421-018-0076-42-s2.0-85061739123YuX.LiuW.FanZ.QianF.ZhangD.HanY.XuL.SunG.QiJ.ZhangS.TangM.LiJ.ChaiR.WangH.c-Myb knockdown increases the neomycin-induced damage to hair-cell-like HEI- OC1 cells in vitro20177110.1038/srep410942-s2.0-85010471654LiA.YouD.LiW.CuiY.HeY.LiW.ChenY.FengX.SunS.ChaiR.LiH.Novel compounds protect auditory hair cells against gentamycin-induced apoptosis by maintaining the expression level of H3K4me220182511033104310.1080/10717544.2018.14612772-s2.0-8506207479830799660MarcottiW.van NettenS. M.KrosC. J.The aminoglycoside antibiotic dihydrostreptomycin rapidly enters mouse outer hair cells through the mechano-electrical transducer channels20055672Part 250552110.1113/jphysiol.2005.0859512-s2.0-2494456602415994187DehneN.RauenU.de GrootH.LautermannJ.Involvement of the mitochondrial permeability transition in gentamicin ototoxicity20021691-2475510.1016/S0378-5955(02)00338-62-s2.0-003601939512121739GuoJ.ChaiR.LiH.SunS.Protection of hair cells from ototoxic drug-induced hearing loss20191130Springer1736GuanM.FangQ.HeZ.LiY.QianF.QianX.LuL.ZhangX.LiuD.QiJ.ZhangS.TangM.GaoX.ChaiR.Inhibition of ARC decreases the survival of HEI-OC-1 cells after neomycin damage in vitro2016741666476665910.18632/oncotarget.113362-s2.0-8499396109427556499HeZ.SunS.WaqasM.ZhangX.QianF.ChengC.ZhangM.ZhangS.WangY.TangM.LiH.ChaiR.Reduced TRMU expression increases the sensitivity of hair-cell-like HEI-OC-1 cells to neomycin damage in vitro20166110.1038/srep296212-s2.0-84978399522SunS.SunM.ZhangY.ChengC.WaqasM.YuH.HeY.XuB.WangL.WangJ.YinS.ChaiR.LiH.In vivo overexpression of X-linked inhibitor of apoptosis protein protects against neomycin-induced hair cell loss in the apical turn of the cochlea during the ototoxic-sensitive period2014810.3389/fncel.2014.002482-s2.0-84907187979PriuskaE. M.SchachtJ.Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex199550111749175210.1016/0006-2952(95)02160-42-s2.0-00295987568615852EsterbergR.HaileyD. W.CoffinA. B.RaibleD. W.RubelE. W.Disruption of intracellular calcium regulation is integral to aminoglycoside-induced hair cell death201333177513752510.1523/JNEUROSCI.4559-12.20132-s2.0-8487658251023616556EsterbergR.LinboT.PickettS. B.WuP.OuH. C.RubelE. W.RaibleD. W.Mitochondrial calcium uptake underlies ROS generation during aminoglycoside-induced hair cell death201612693556356610.1172/JCI849392-s2.0-8498785012627500493DesaD. E.BhanoteM.HillR. L.MajeskiJ. B.BuscagliaB.D’AguiarM.StrawdermanR.HicksD. G.TurnerB. M.BrownE. B.Second-harmonic generation directionality is associated with neoadjuvant chemotherapy response in breast cancer core needle biopsies201924811410.1117/1.JBO.24.8.0865032-s2.0-85071626895Jensen-SmithH. C.HallworthR.NicholsM. G.Gentamicin rapidly inhibits mitochondrial metabolism in high-frequency cochlear outer hair cells201276, article e3847110.1371/journal.pone.00384712-s2.0-8486200600122715386MukherjeaD.JajooS.KaurT.SheehanK. E.RamkumarV.RybakL. P.Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat201013558959810.1089/ars.2010.31102-s2.0-7795493593420214492AlamS. A.IkedaK.OshimaT.SuzukiM.KawaseT.KikuchiT.TakasakaT.Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea20001411-2283810.1016/S0378-5955(99)00211-72-s2.0-003410169610713493PfannenstielS. C.PraetoriusM.PlinkertP. K.BroughD. E.StaeckerH.Bcl-2 gene therapy prevents aminoglycoside-induced degeneration of auditory and vestibular hair cells200914425426610.1159/0001929532-s2.0-5824908329819151550WangY.Loss of CIB2 causes profound hearing loss and abolishes mechanoelectrical transduction in mice20171010.3389/fnmol.2017.004012-s2.0-85041805921ZhuC.ChengC.WangY.MuhammadW.LiuS.ZhuW.ShaoB.ZhangZ.YanX.HeQ.XuZ.YuC.QianX.LuL.ZhangS.ZhangY.XiongW.GaoX.XuZ.ChaiR.Loss of ARHGEF6 causes hair cell stereocilia deficits and hearing loss in mice20181110.3389/fnmol.2018.003622-s2.0-85054871501HeY.LuX.QianF.LiuD.ChaiR.LiH.Insm1a is required for zebrafish posterior lateral line development20171010.3389/fnmol.2017.002412-s2.0-85027839995KremerH.Hereditary hearing loss; about the known and the unknown2019376586810.1016/j.heares.2019.01.0032-s2.0-8506008266330665849GuanM. X.Molecular pathogenetic mechanism of maternally inherited deafness20041011125927110.1196/annals.1293.0252-s2.0-1842678661DingY.LengJ.FanF.XiaB.XuP.The role of mitochondrial DNA mutations in hearing loss2013517-858860210.1007/s10528-013-9589-62-s2.0-8488060351223605717MengF.HeZ.TangX.ZhengJ.JinX.ZhuY.RenX.ZhouM.WangM.GongS.MoJ. Q.ShuQ.GuanM.-X.Contribution of the tRNAIle 4317A->G mutation to the phenotypic manifestation of the deafness-associated mitochondrial 12S rRNA 1555A->G mutation201829393321333410.1074/jbc.RA117.0005302-s2.0-8504291347429348176XueL.ChenY.TangX.YaoJ.HuangH.WangM.YeS.WangM.GuanM.-X.A deafness-associated mitochondrial DNA mutation altered the tRNASer(UCN) metabolism and mitochondrial function20194637037910.1016/j.mito.2018.10.0012-s2.0-8505547658230336267QianF.WangX.YinZ.XieG.YuanH.LiuD.ChaiR.The slc4a2b gene is required for hair cell development in zebrafish20201219188041882110.18632/aging.10384033044947TangX.LiR.ZhengJ.CaiQ.ZhangT.GongS.ZhengW.HeX.ZhuY.XueL.YangA.YangL.LuJ.GuanM.-X.Maternally inherited hearing loss is associated with the novel mitochondrial tRNASer(UCN) 7505T>C mutation in a Han Chinese family20101001576410.1016/j.ymgme.2010.01.0082-s2.0-7795052014920153673LiR.IshikawaK.DengJ.-H.Heman-AckahS.TamagawaY.YangL.BaiY.IchimuraK.GuanM.-X.Maternally inherited nonsyndromic hearing loss is associated with the T7511C mutation in the mitochondrial tRNASer(UCN) gene in a Japanese family20053281323710.1016/j.bbrc.2004.12.1402-s2.0-1284428616115670746LabayV.GarridoG.MadeoA. C.NanceW. E.FriedmanT. B.FriedmanP. L.Del CastilloI.GriffithA. J.Haplogroup analysis supports a pathogenic role for the 7510T>C mutation of mitochondrial tRNA(Ser(UCN)) in sensorineural hearing loss2008731505410.1111/j.1399-0004.2007.00925.x2-s2.0-3724907689018028453FanW.ZhengJ.KongW.CuiL.AishanjiangM.YiQ.WangM.CangX.TangX.ChenY.MoJ. Q.SondheimerN.GeW.GuanM.-X.Contribution of a mitochondrial tyrosyl-tRNA synthetase mutation to the phenotypic expression of the deafness-associated tRNASer(UCN) 7511A>G mutation201929450192921930510.1074/jbc.RA119.01059831685661ZhangQ.ZhangL.ChenD.HeX.YaoS.ZhangZ.ChenY.GuanM.-X.Deletion of Mtu1 (Trmu) in zebrafish revealed the essential role of tRNA modification in mitochondrial biogenesis and hearing function20184620109301094510.1093/nar/gky7582-s2.0-8505659294630137487ChenD.LiF.YangQ.TianM.ZhangZ.ZhangQ.ChenY.GuanM.-X.The defective expression of _gtpbp3_ related to tRNA modification alters the mitochondrial function and development of zebrafish201677Part A1910.1016/j.biocel.2016.05.0122-s2.0-8497132046927184967DenuJ. M.The Sir2 family of protein deacetylases20059543144010.1016/j.cbpa.2005.08.0102-s2.0-2514449690416122969SchwerB.VerdinE.Conserved metabolic regulatory functions of sirtuins20087210411210.1016/j.cmet.2007.11.0062-s2.0-3864912307218249170HaigisM. C.SinclairD. A.Mammalian sirtuins: biological insights and disease relevance20105125329510.1146/annurev.pathol.4.110807.0922502-s2.0-7794988750620078221VerdinE.HirscheyM. D.FinleyL. W. S.HaigisM. C.Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling2010351266967510.1016/j.tibs.2010.07.0032-s2.0-7864932879920863707DuJ.ZhouY.SuX.YuJ. J.KhanS.JiangH.KimJ.WooJ.KimJ. H.ChoiB. H.HeB.ChenW.ZhangS.CerioneR. A.AuwerxJ.HaoQ.LinH.Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase2011334605780680910.1126/science.12078612-s2.0-8105512267122076378MathiasR. A.GrecoT. M.ObersteinA.BudayevaH. G.ChakrabartiR.RowlandE. A.KangY.ShenkT.CristeaI. M.Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity201415971615162510.1016/j.cell.2014.11.0462-s2.0-8491993374925525879AhnB.-H.KimH.-S.SongS.LeeI. H.LiuJ.VassilopoulosA.DengC.-X.FinkelT.A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis200810538144471445210.1073/pnas.08037901052-s2.0-5574908473818794531SomeyaS.YuW.HallowsW. C.XuJ.VannJ. M.LeeuwenburghC.TanokuraM.DenuJ. M.ProllaT. A.Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction2010143580281210.1016/j.cell.2010.10.0022-s2.0-7865146872221094524HirscheyM. . D.ShimazuT.JingE.GrueterC. . A.CollinsA. . M.AouizeratB.StančákováA.GoetzmanE.LamM. . M.SchwerB.StevensR. . D.MuehlbauerM. . J.KakarS.BassN. . M.KuusistoJ.LaaksoM.AltF. . W.NewgardC. . B.FareseR. . V.KahnC. R.VerdinE.SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome201144217719010.1016/j.molcel.2011.07.0192-s2.0-8245521290121856199HallowsW. C.LeeS.DenuJ. M.Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases200610327102301023510.1073/pnas.06043921032-s2.0-3374593107416790548TaoR.ColemanM. C.PenningtonJ. D.OzdenO.ParkS.-H.JiangH.KimH.-S.FlynnC. R.HillS.McDonaldW. H.OlivierA. K.SpitzD. R.GiusD.Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress201040689390410.1016/j.molcel.2010.12.0132-s2.0-7865024816021172655YuW.Dittenhafer-ReedK. E.DenuJ. M.SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status201228717140781408610.1074/jbc.M112.3552062-s2.0-8485995179022416140TsengA. H. H.ShiehS.-S.WangD. L.SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage20136322223410.1016/j.freeradbiomed.2013.05.0022-s2.0-8487905976623665396HanC.SomeyaS.Maintaining good hearing: calorie restriction, Sirt3, and glutathione201348101091109510.1016/j.exger.2013.02.0142-s2.0-8488345156623454634QiuX.BrownK.HirscheyM. D.VerdinE.ChenD.Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation201012666266710.1016/j.cmet.2010.11.0152-s2.0-7864952124721109198SamantS. A.ZhangH. J.HongZ.PillaiV. B.SundaresanN. R.WolfgeherD.ArcherS. L.ChanD. C.GuptaM. P.SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress201434580781910.1128/MCB.01483-132-s2.0-8489381999124344202BrownK. . D.MaqsoodS.HuangJ.-Y.PanY.HarkcomW.LiW.SauveA.VerdinE.JaffreyS. . R.Activation of SIRT3 by the NAD+ precursor nicotinamide riboside protects from noise-induced hearing loss20142061059106810.1016/j.cmet.2014.11.0032-s2.0-8491969417925470550QuanY.XiaL.ShaoJ.YinS.ChengC. Y.XiaW.GaoW.-Q.Adjudin protects rodent cochlear hair cells against gentamicin ototoxicity via the SIRT3-ROS pathway20155110.1038/srep081812-s2.0-84944466391HaigisM. C.MostoslavskyR.HaigisK. M.FahieK.ChristodoulouD. C.MurphyA. . J.ValenzuelaD. M.YancopoulosG. D.KarowM.BlanderG.WolbergerC.ProllaT. A.WeindruchR.AltF. W.GuarenteL.SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic β cells2006126594195410.1016/j.cell.2006.06.0572-s2.0-3374831653616959573LombardD. B.TishkoffD. X.BaoJ.Mitochondrial sirtuins in the regulation of mitochondrial activity and metabolic adaptation201120616318810.1007/978-3-642-21631-2_82-s2.0-80054746880SchlickerC.GertzM.PapatheodorouP.KachholzB.BeckerC. F. W.SteegbornC.Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt52008382379080110.1016/j.jmb.2008.07.0482-s2.0-50149103440NasrinN.WuX.FortierE.FengY.Bare’O. C.ChenS.RenX.WuZ.StreeperR. S.BordoneL.SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells201028542319953200210.1074/jbc.M110.1241642-s2.0-7795776268720685656LaurentG.GermanN. . J.SahaA. . K.de BoerV. . C. J.DaviesM.KovesT. . R.DephoureN.FischerF.BoancaG.VaitheesvaranB.LovitchS. . B.SharpeA. . H.KurlandI. . J.SteegbornC.GygiS. . P.MuoioD. . M.RudermanN. . B.HaigisM. . C.SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase201350568669810.1016/j.molcel.2013.05.0122-s2.0-8487889162523746352LuoY.-X.TangX.AnX.-Z.XieX.-M.ChenX.-F.ZhaoX.HaoD.-L.ChenH.-Z.LiuD.-P.SIRT4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity201738181389139810.1093/eurheartj/ehw1382-s2.0-85019716725LangA.Grether-BeckS.SinghM.KuckF.JakobS.KefalasA.Altinoluk-HambüchenS.GraffmannN.SchneiderM.LindeckeA.BrendenH.FelsnerI.EzzahoiniH.MariniA.WeinholdS.VierkötterA.TiggesJ.SchmidtS.StühlerK.KöhrerK.UhrbergM.HaendelerJ.KrutmannJ.PiekorzR. P.MicroRNA-15b regulates mitochondrial ROS production and the senescence-associated secretory phenotype through sirtuin 4/SIRT420168348450510.18632/aging.1009052-s2.0-8496970323326959556FryeR. A.Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins2000273279379810.1006/bbrc.2000.30002-s2.0-003388745610873683MichishitaE.ParkJ. Y.BurneskisJ. M.BarrettJ. C.HorikawaI.Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins200516104623463510.1091/mbc.e05-01-00332-s2.0-2624443628116079181LombardD. B.AltF. W.ChengH.-L.BunkenborgJ.StreeperR. S.MostoslavskyR.KimJ.YancopoulosG.ValenzuelaD.MurphyA.YangY.ChenY.HirscheyM. D.BronsonR. T.HaigisM.GuarenteL. P.FareseR. V.WeissmanS.VerdinE.SchwerB.Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation200727248807881410.1128/MCB.01636-072-s2.0-3754900289117923681PengC.LuZ.XieZ.ChengZ.ChenY.TanM.LuoH.ZhangY.HeW.YangK.ZwaansB. M. M.TishkoffD.HoL.LombardD.HeT.-C.DaiJ.VerdinE.YeY.ZhaoY.The first identification of lysine malonylation substrates and its regulatory enzyme20111012M111.01265810.1074/mcp.m111.0126582-s2.0-8305517330421908771NakagawaT.LombD. J.HaigisM. C.GuarenteL.SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle2009137356057010.1016/j.cell.2009.02.0262-s2.0-6524908738919410549OguraM.NakamuraY.TanakaD.ZhuangX.FujitaY.ObaraA.HamasakiA.HosokawaM.InagakiN.Overexpression of SIRT5 confirms its involvement in deacetylation and activation of carbamoyl phosphate synthetase 120103931737810.1016/j.bbrc.2010.01.0812-s2.0-7724912835220097174ZhouL.WangF.SunR.ChenX.ZhangM.XuQ.WangY.WangS.XiongY.GuanK.‐. L.YangP.YuH.YeD.SIRT5 promotes IDH2 desuccinylation and G6PD deglutarylation to enhance cellular antioxidant defense201617681182210.15252/embr.2015416432-s2.0-8497150503027113762WangY.ZhuY.XingS.MaP.LinD.SIRT5 prevents cigarette smoke extract-induced apoptosis in lung epithelial cells via deacetylation of FOXO3201520580581010.1007/s12192-015-0599-72-s2.0-8493875148525981116LinZ.-F.XuH.-B.WangJ.-Y.LinQ.RuanZ.LiuF.-B.JinW.HuangH.-H.ChenX.SIRT5 desuccinylates and activates SOD1 to eliminate ROS2013441119119510.1016/j.bbrc.2013.10.0332-s2.0-8488741252524140062van de VenR. A. H.SantosD.HaigisM. C.Mitochondrial sirtuins and molecular mechanisms of aging201723432033110.1016/j.molmed.2017.02.0052-s2.0-8501470869528285806